Clinical Trial Update: S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for S0801 evaluating iodine-131 tositumomab, rituximab, and combination chemotherapy in previously untreated follicular non-Hodgkin lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• Tositumomab (I-131 labeled) (tositumomab)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2018-11-15